AMAZON COM INC
For the period ended Sep 30, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 30, 2026
AMZN$270.87+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
(in millions)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | Twelve Months EndedSeptember 30, | ||||
|---|---|---|---|---|---|---|
| 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | |
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD | $61,453 | $80,927 | $82,312 | $90,106 | $78,677 | $70,464 |
| OPERATING ACTIVITIES: | ||||||
| Net income | 21,187 | 20,685 | 56,478 | 113,587 | 76,482 | 134,779 |
| Adjustments to reconcile net income to net cash from operating activities: | ||||||
| Depreciation and amortization of property and equipment and capitalized content costs, operating lease assets, and other | 16,796 | 20,949 | 46,285 | 59,882 | 61,916 | 79,353 |
| Stock-based compensation | 4,847 | 5,406 | 15,070 | 15,476 | 20,065 | 19,873 |
| Non-operating expense (income), net | (10,112) | 694 | (14,187) | (68,319) | (14,673) | (69,012) |
| Deferred income taxes | 10,130 | 5,033 | 10,648 | 35,522 | 9,040 | 36,344 |
| Changes in operating assets and liabilities: | ||||||
| Inventories | (827) | (4,516) | (6,103) | (4,712) | (5,169) | (1,611) |
| Accounts receivable, net and other | (1,977) | (2,127) | (1,855) | (16,081) | (5,878) | (21,559) |
| Other assets | (4,039) | (4,637) | (10,412) | (13,165) | (14,602) | (18,385) |
| Accounts payable | 2,151 | 1,502 | 166 | 2,207 | 8,892 | 13,272 |
| Accrued expenses and other | (1,999) | (3,848) | (11,012) | (13,911) | (6,970) | (7,918) |
| Unearned revenue | (632) | 3,281 | (23) | 3,355 | 1,588 | 3,164 |
| Net cash provided by (used in) operating activities | 35,525 | 42,422 | 85,055 | 113,841 | 130,691 | 168,300 |
| INVESTING ACTIVITIES: | ||||||
| Purchases of property and equipment | (35,095) | (77,259) | (92,297) | (175,670) | (120,131) | (215,192) |
| Proceeds from property and equipment sales and incentives | 867 | 1,381 | 2,446 | 3,482 | 4,228 | 4,535 |
| Acquisitions, net of cash acquired, non-marketable investments, and other, net | (786) | (23,986) | (2,438) | (63,753) | (4,973) | (65,156) |
| Sales and maturities of marketable securities | 16,367 | 23,677 | 35,545 | 65,559 | 39,222 | 74,400 |
| Purchases of marketable securities | (7,426) | (37,455) | (38,556) | (86,717) | (51,089) | (102,931) |
| Net cash provided by (used in) investing activities | (26,073) | (113,642) | (95,300) | (257,099) | (132,743) | (304,344) |
| FINANCING ACTIVITIES: | ||||||
| Proceeds from short-term debt, and other | 3,223 | 5,307 | 7,131 | 20,693 | 9,685 | 22,882 |
| Repayments of short-term debt, and other | (1,826) | (3,927) | (5,300) | (19,609) | (7,907) | (22,735) |
| Proceeds from long-term debt | — | 48,102 | 746 | 115,100 | 746 | 130,027 |
| Repayments of long-term debt | (1,008) | (7) | (3,759) | (2,759) | (6,259) | (4,021) |
| Principal repayments of finance leases | (351) | (433) | (1,172) | (1,296) | (1,505) | (1,681) |
| Principal repayments of financing obligations | (82) | (107) | (276) | (281) | (698) | (333) |
| Net cash provided by (used in) financing activities | (44) | 48,935 | (2,630) | 111,848 | (5,938) | 124,139 |
| Foreign currency effect on cash, cash equivalents, and restricted cash | (397) | 72 | 1,027 | 18 | (223) | 155 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 9,011 | (22,213) | (11,848) | (31,392) | (8,213) | (11,750) |
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD | $70,464 | $58,714 | $70,464 | $58,714 | $70,464 | $58,714 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.